Free Newsletter
Garnier hired to restructure French firm
Free newsletter via e-mail
Tools
What's GlaxoSmithKline's ex-CEO Jean-Pierre Garnier up to these days? Well, in addition to director and advisory roles he holds at United Technologies, Renault, and the sovereign fund Dubai Capital, Garnier is expected to "return to his French roots" as chief executive of the health and beauty company Pierre Fabre.
As you know, Garnier retired from GSK in May, leaving new CEO Andrew Witty in charge. His mandate at Fabre, the Financial Times reports, will be the restructuring of the company, which is located in southwest France. Garnier has plenty of experience at overhauls: He engineered a big one, with thousands of layoffs, just before turning over GSK's reins to Witty.
- see the FT story
Related Articles:
GSK's Garnier: FDA raised the bar for new drugs
GSK's Garnier gets $4.9M handshake
'No regrets,' says newly retired JP Garnier
GSK's Garnier to join Dubai equity firm
GSK taps Witty as next CEO
Comments
Post new comment
Paid Research Reports
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
- Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion and combination products
- The CRO Market Outlook: Emerging markets, leading players and future trends
- Pharmaceutical Sales Force Effectiveness Strategies
- Commercial Insight: Influenza Vaccines and Antivirals - The pandemic's long-term impact
